Diagnostic testing for SARS-CoV-2 and influenza viruses can guide clinical management, including appropriate antiviral treatment, particularly in persons at higher risk for progression to severe disease from COVID-19 and influenza, regardless of vaccination status. Antivirals are available that can reduce the risk of severe illness and death from COVID-19 and mitigate influenza illness.
During this COCA Call, subject matter experts will present an overview of COVID-19 and influenza therapeutic options, including eligibility, indications, and efficacy.
Thursday, February 1, 2024 | 1:00 – 2:00 p.m. CT
Registration is NOT required.
At the conclusion of the session, the participant will be able to accomplish the following:
- List available tests and when to test for SARS-CoV-2 and influenza viruses, including indications for repeat testing.
- Describe recommended antivirals for treating influenza and COVID-19 and clinical benefits.
- Cite factors for deciding who to treat for COVID-19 and influenza.
- Review indications for empiric treatment of influenza and COVID-19.
Speakers:
Pragna Patel, MD, MPH
Chief Medical Officer
Coronavirus and Other Respiratory Viruses Division
National Center for Immunization and Respiratory Diseases
Centers for Disease Control and Prevention
Tim Uyeki, MD, MPH, MPP
Chief Medical Officer
Influenza Division
National Center for Immunization and Respiratory Diseases
Centers for Disease Control and Prevention
If you are unable to attend the live COCA Call, the recording will be available for viewing on the COCA Call webpage a few hours after the live event ends. The slide set will be available on the day of the call on the COCA Call webpage under Call Materials.
Continuing Education
Free Continuing Education (CE) will be offered for this COCA Call.
To receive continuing education (CE) for WC4520R—Diagnostic Testing and Treatment Guidelines for COVID-19 and Influenza—please visit CDC TRAIN and search for the course in the Course Catalog using WC4520R-020124. Follow the steps below by March 4, 2024.
To receive continuing education (CE) for WD4520R—Diagnostic Testing and Treatment Guidelines for COVID-19 and Influenza—please visit CDC TRAIN and search for the course in the Course Catalog using WD4520R-020124. Follow the steps below between March 5, 2024, and March 5, 2026.
1. Register for and complete the course.
2. Pass the post-assessment at 75%.
3. Complete the evaluation.
4. Visit Your Learning to access your certificates and transcript.